{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:18:07Z","timestamp":1793499487114,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.steroids.2013.04.004","type":"journal-article","created":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T08:46:56Z","timestamp":1366793216000},"page":"782-785","source":"Crossref","is-referenced-by-count":206,"title":["Cancer risk and PCOS"],"prefix":"10.1016","volume":"78","author":[{"given":"Daniel A.","family":"Dumesic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogerio A.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2013.04.004_b0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.steroids.2013.04.004_b0010","unstructured":"ACOG Practice Bulletin. Management of endometrial. cancer 2005;65."},{"issue":"Suppl. 1","key":"10.1016\/j.steroids.2013.04.004_b0015","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.steroids.2013.04.004_b0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bpobgyn.2008.11.010","article-title":"Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer","volume":"24","author":"Papaioannou","year":"2010","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.steroids.2013.04.004_b0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2007-992926","article-title":"Polycystic ovary syndrome and endometrial cancer","volume":"26","author":"Navaratnarajah","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.steroids.2013.04.004_b0030","first-page":"332","article-title":"Carcinoma of the endometrium in young women","volume":"88","author":"Speert","year":"1949","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.steroids.2013.04.004_b0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.steroids.2013.04.004_b0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0002-9378(16)37277-5","article-title":"The Stein-Leventhal syndrome: analysis of 43 cases with special reference to association with endometrial carcinoma","volume":"73","author":"Jackson","year":"1957","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.steroids.2013.04.004_b0045","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","article-title":"Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review","volume":"19","author":"Chittenden","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.steroids.2013.04.004_b0050","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/humrep\/des042","article-title":"Evaluating the association between endometrial cancer and polycystic ovary syndrome","volume":"27","author":"Haoula","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.steroids.2013.04.004_b0055","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s10552-010-9658-7","article-title":"Australian Ovarian Cancer Study Group and Australian National Endometrial Cancer Study Group. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study","volume":"21","author":"Fearnley","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.steroids.2013.04.004_b0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2009.03.039","article-title":"Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship","volume":"114","author":"Fader","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"28\u201338","key":"10.1016\/j.steroids.2013.04.004_b0065","first-page":"e25","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2013.04.004_b0070","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.maturitas.2008.12.018","article-title":"Progestogen deficiency and endometrial cancer risk","volume":"62","author":"Schindler","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.steroids.2013.04.004_b0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0029-7844(01)01432-6","article-title":"Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome","volume":"98","author":"Cheung","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.steroids.2013.04.004_b0080","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2010-2600","article-title":"Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles","volume":"96","author":"Savaris","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2013.04.004_b0085","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/jc.85.11.4047","article-title":"Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"85","author":"Eagleson","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.steroids.2013.04.004_b0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ijc.11529","article-title":"Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women","volume":"108","author":"Lukanova","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.steroids.2013.04.004_b0095","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/jcem-62-3-508","article-title":"Ovarian steroid secretion in postmenopausal women with and without endometrial cancer","volume":"62","author":"Nagamani","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2013.04.004_b0100","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/88.16.1127","article-title":"Case-control study of endogenous steroid hormones and endometrial cancer","volume":"88","author":"Potischman","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.steroids.2013.04.004_b0105","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ijc.10394","article-title":"Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders","volume":"99","author":"Ito","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.steroids.2013.04.004_b0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1095\/biolreprod66.2.297","article-title":"Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome","volume":"66","author":"Apparao","year":"2002","journal-title":"Biol Reprod"},{"key":"10.1016\/j.steroids.2013.04.004_b0115","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.fertnstert.2005.09.053","article-title":"Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome","volume":"85","author":"Quezada","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2013.04.004_b0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.steroids.2013.04.004_b0125","first-page":"4281","article-title":"Luteinizing hormone increases human endometrial cancer cells invasiveness through activation of protein kinase A","volume":"63","author":"Dabizzi","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2013.04.004_b0130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/gyno.1997.4656","article-title":"Increased expression of LH\/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women","volume":"65","author":"Konishi","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.steroids.2013.04.004_b0135","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/jc.79.5.1483","article-title":"Increased expression of luteinizing hormone\/human chorionic gonadotropin receptor gene in human endometrial carcinomas","volume":"79","author":"Lin","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2013.04.004_b0140","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and Implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.steroids.2013.04.004_b0145","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2013.04.004_b0150","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1210\/jc.2008-1612","article-title":"Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome","volume":"94","author":"Kim","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2013.04.004_b0155","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1210\/jc.2010-1803","article-title":"Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells","volume":"96","author":"Tan","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2013.04.004_b0160","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/jc.2009-1158","article-title":"Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}","volume":"95","author":"Chazenbalk","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2013.04.004_b0165","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/jcp.21622","article-title":"Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation","volume":"218","author":"Catalano","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.steroids.2013.04.004_b0170","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1677\/ERC-07-0065","article-title":"Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2","volume":"14","author":"Cong","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.steroids.2013.04.004_b0175","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09513590312331290298","article-title":"Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent","volume":"17","author":"Session","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.steroids.2013.04.004_b0180","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5653\/cerm.2011.38.1.42","article-title":"Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome","volume":"38","author":"Park","year":"2011","journal-title":"Clin Exp Reprod Med"},{"key":"10.1016\/j.steroids.2013.04.004_b0185","series-title":"Clinical gynecologic endocrinology and infertility","author":"Speroff","year":"2005"},{"key":"10.1016\/j.steroids.2013.04.004_b0190","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/humrep\/12.9.1851","article-title":"Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner\u2019s guide to meta-analysis","volume":"12","author":"Schlesselman","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.steroids.2013.04.004_b0195","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer. Findings in a large cohort study, 1968\u20132004","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.steroids.2013.04.004_b0200","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner\u2019s oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.steroids.2013.04.004_b0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bpobgyn.2009.08.010","article-title":"The use of hormonal contraception and its protective role against endometrial and ovarian cancer","volume":"24","author":"Grimbizis","year":"2010","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.steroids.2013.04.004_b0210","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0029-7844(96)00226-8","article-title":"Epithelial ovarian cancer risk among women with polycystic ovary syndrome","volume":"88","author":"Schildkraut","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.steroids.2013.04.004_b0215","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humupd\/7.6.522","article-title":"Polycystic ovary syndrome and cancer","volume":"7","author":"Balen","year":"2001","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.steroids.2013.04.004_b0220","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"1590\u20131601","key":"10.1016\/j.steroids.2013.04.004_b0225","first-page":"e1","article-title":"Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration","volume":"98","author":"Galazis","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2013.04.004_b0230","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10549-012-2170-x","article-title":"Metformin and breast cancer risk: a meta-analysis and critical literature review","volume":"135","author":"Col","year":"2012","journal-title":"Breast Cancer ResTreat"},{"key":"10.1016\/j.steroids.2013.04.004_b0235","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.canlet.2012.05.019","article-title":"Adipose tissue and breast epithelial cells: a dangerous dynamic duo in breast cancer","volume":"324","author":"Wang","year":"2012","journal-title":"Cancer Lett"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X1300086X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X1300086X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T15:50:30Z","timestamp":1539705030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X1300086X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0039128X1300086X"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2013.04.004","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}